Good News


Recent Good News Stories

Elecoglipron lowered HbA1c and body weight in a phase 2 trial, pointing to a simpler oral option for type 2 diabetes.
A once-daily oral GLP-1 drug cut blood sugar and weight in adults with type 2 diabetes in a new phase 2b trial.
Hannah Shavit-Weinerupda